Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.0%

8 terminated/withdrawn out of 797 trials

Success Rate

94.8%

+8.2% vs industry average

Late-Stage Pipeline

11%

90 trials in Phase 3/4

Results Transparency

6 of 146 completed trials have results

Key Signals

174 recruiting6 with results

Enrollment Performance

Analytics

N/A

268(53.2%)

Phase 2

100(19.8%)

Phase 4

55(10.9%)

Phase 3

35(6.9%)

Phase 1

31(6.2%)

Early Phase 1

15(3.0%)

504Total

N/A(268)

Phase 2(100)

Phase 4(55)

Phase 3(35)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (797)

Showing 20 of 797 trials

NCT07856355Phase 4Not Yet Recruiting

Tobramycin Nebulization to Prevent Multidrug-Resistant Ventilator-Associated Pneumonia

Role: collaborator

NCT07854197Not ApplicableNot Yet Recruiting

Effect of Remimazolam on Hypoxemia and/or Hypotension in Prostate Biopsy

Role: lead

NCT07582731Not ApplicableRecruiting

A Multi-Center Randomized Controlled Trial on the Impact of Disease Subtype-Based Active Video Education on Bowel Preparation Quality in Patients With Inflammatory Bowel Disease

Role: collaborator

NCT07833046Not Yet Recruiting

Long-term Follow-up Study in Subjects With Multiple Myeloma Previously Treated With GC012F Injection

Role: lead

NCT07744659Not ApplicableRecruiting

Spinal Cord Stimulation for Poststroke Spasticity

Role: collaborator

NCT04698304Completed

The Efficacy of Endovascular Treatment in FPOD With TASC C and D Lesions

Role: lead

NCT05831891Phase 2Active Not Recruiting

Fruquintinib Plus Serplulimab as First-Line Therapy for Metastatic Non-Clear Cell Renal Cell Carcinoma

Role: lead

NCT07383909Not ApplicableRecruiting

Remote Ischemic Preconditioning for Aute Type A Aortic Dissection Surgery

Role: collaborator

NCT07690306Enrolling By Invitation

Development and Validation of a Non-Invasive AI Diagnostic Model for Prostate Cancer Using Multiparametric MRI and PSMA PET/CT

Role: collaborator

NCT07815483Not Yet Recruiting

A Multicenter Cohort Study of AI-Based Methods for Pulmonary Nodule Diagnosis and Follow-up

Role: collaborator

NCT05877820Phase 2Completed

A Study to Evaluate Efficacy and Safety of Lenvatinib Combined With Tislelizumab in Patients With FHRCC

Role: lead

NCT06358209Not ApplicableRecruiting

Safety and Efficacy of Ventricular Irrigation for Ventriculitis

Role: lead

NCT07811895Not ApplicableNot Yet Recruiting

Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer

Role: lead

NCT07622199Not ApplicableRecruiting

PROfunda Femoris Vein Thrombosis Evaluation and Clearance to Improve Outcomes of Endovascular Treatment for Acute Iliofemoral Deep Vein Thrombosis

Role: lead

NCT07632235Phase 1Not Yet Recruiting

A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma

Role: collaborator

NCT07323173Phase 1Recruiting

A Study to Assess the Safety and PK/PD of LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus

Role: collaborator

NCT07782294Not Yet Recruiting

AI-Assisted Novel rbcDNA Detection for Early Gastric Cancer Diagnosis

Role: collaborator

NCT07776626Phase 1Recruiting

Phase I Exploratory Study of YOLT-203 in Patients With Primary Hyperoxaluria Type 1 (PH1)

Role: collaborator

NCT07185373Phase 2Recruiting

Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL